Qube Research & Technologies LTD Albemarle Corp Call Options Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$72.85 - $100.09 $8.72 Million - $12 Million	119,700 Added 58.14%	325,600 $30.8 Million
Q2 2024 Aug 14, 2024	BUY	$92.77 - $135.46 $18.3 Million - $26.7 Million	197,000 Added 2213.48%	205,900 $19.7 Million
Q1 2024 May 14, 2024	SELL	$108.73 - $146.89 $3.49 Million - $4.72 Million	-32,100 Reduced 78.29%	8,900 $1.17 Million
Q4 2023 Feb 13, 2024	BUY	$113.26 - $170.8 $4.15 Million - $6.25 Million	36,600 Added 831.82%	41,000 $5.92 Million
Q3 2023 Nov 13, 2023	BUY	$162.63 - $243.44 $715,572 - $1.07 Million	4,400 New	4,400 $748,000

927

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $10.5B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.